Bcma-targeted chimeric antigen receptors

EP4255936A4Pending Publication Date: 2025-01-22SHANGHAI ABELZETA LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
EP2021901383
Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-09-16
Filing Date
2021-12-01
Publication Date
2025-01-22

Smart Images

  • Figure 1.1
    Figure 1.1
Patent Text Reader

Abstract

The present disclosure provides BCMA-targeted chimeric antigen receptors (CARs) as well as preparation methods and applications thereof. The CARs of the present disclosure targets BCMA-positive cells, and can be used for treating BCMA-positive B-cell lymphoma, multiple myeloma and plasma cell leukemia.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Chimeric antigen receptors targeting b-cell maturation antigen

    US20150051266A1

  • Anti-BCMA car t cell compositions

    US20200261501A1

  • BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereof

    WO2019196713A1

  • Dosing regimen for BCMA-CD3 bispecific antibodies

    WO2020025596A1